National Bank of Canada
DYN icon

National Bank of Canada’s Dyne Therapeutics DYN Stock Holding History

National Bank of Canada’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.62K Hold
200
– – ﹤0.01% 2519
2025
Q4 		$3.91K Buy
200
+50
+33% +$947 ﹤0.01% 2478
2025
Q3 		$1.9K Buy
150
+99
+194% +$1.13K ﹤0.01% 2596
2025
Q2 		$486 Buy
51
+50
+5,000% +$550 ﹤0.01% 2769
2025
Q1 		$10 Buy
+1
New +$14 ﹤0.01% 2795
2024
Q4 		– Sell
-1
Closed -$36 – 3006
2024
Q3 		$36 Buy
+1
New +$40 ﹤0.01% 2607

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return

National Bank of Canada's DYN Position: Q1 2026 in Review

National Bank of Canada held its Dyne Therapeutics (DYN) position steady in Q1 2026 at 200 shares worth $3.62K. The position accounts for ﹤0.01% of the portfolio, ranked #2519.

National Bank of Canada first reported a position in DYN in Q3 2024 and has held it in 6 quarters since. The position peaked at $3.91K in Q4 2025. 227 funds tracked by Wall St. Rank hold DYN as of Q1 2026.

  • National Bank of Canada held 200 shares of Dyne Therapeutics worth $3.62K as of Q1 2026.
  • National Bank of Canada left its Dyne Therapeutics share count unchanged in Q1 2026.
  • Dyne Therapeutics made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2519 holding.
  • National Bank of Canada first reported a position in Dyne Therapeutics in Q3 2024 and has held it in 6 quarters since.
  • National Bank of Canada's Dyne Therapeutics position peaked at $3.91K in Q4 2025.
  • 227 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.